Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Thyroid hormone receptors are essential for hair growth and wound healing.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.

Hair loss and polyneuropathy improved, but severe vision impairment persisted.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

TQC shows promise for better hair regrowth in treating hair loss.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Different thymic peptides affect hair growth in various ways.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Thymic peptides can either promote or inhibit human hair growth.

TCDD changes skin cell growth and keratin production in mice.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

ALRN-6924 may prevent hair loss caused by chemotherapy.